NCT05150691 2026-01-28A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting796 enrolled
NCT02507375 2015-10-16A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Hoffmann-La RochePhase 1 Completed17 enrolled 15 charts
NCT00063154 2015-07-07Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior ChemotherapyGenentech, Inc.Phase 2 Completed51 enrolled 9 charts